Footnotes

Chapter 1 - Introduction

[1]        DOHA, New PBS Safety Net Thresholds, http://www.health.gov.au/internet/main/publishing.nsf/Content/pbs-safetynet-changes (accessed 26 September 2011).

[2]        DOHA, Submission 24, p. 5.

[3]        DOHA, Submission 24, p. 5.

[4]        DOHA, Alternative Arrangements for Medicines, http://www.health.gov.au/internet/main/publishing.nsf/Content/health-pbs-indigenous-eligibility (accessed 12 July 2011).

[5]        Australian Bureau of Statistics, 8689.0 - Private Medical Practitioners, Australia, 2002, http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/8689.0Explanatory%20Notes12002 (accessed 30 August 2011). The RRMA Classification has been used to classify the geographical location of medical practitioners according to their main private practice address. The RRMA classification was originally developed in 1994 by the former departments of Primary Industry and Energy, and Human Services and Health. The original RRMA classification assigned locations to seven categories according to geographic boundaries based on the 1991 population census.

[6]        DOHA website, http://www.health.gov.au/internet/main/publishing.nsf/Content/health-pbs-indigenous-remuneration (accessed 12 July 2011).

[7]        Keys-Young, Aboriginal and Torres Strait Islander access to Medicare and the Pharmaceutical Benefits Scheme, 1996, Health Insurance Commission, Canberra.

[8]        Centre for Remote Health, Submission 10, p. 4.

[9]        AIHW, Expenditure on health for Aboriginal and Torres Strait Islander people 2008-09, Health and welfare expenditure series no. 44. Cat. no. HWE 53, p. 18, http://www.aihw.gov.au/publication-detail/?id=10737419257&tab=2 (accessed 18 July 2011).

[10]      Centre for Remote Health, Submission 10, p. 4.

[11]      Society of Hospital Pharmacists, Submission 3, p. 3.

[12]      DOHA, Submission 24, p. 5.

[13]      DOHA, Submission 24, p. 4.

[14]      Chart kindly supplied by DOHA.

[15]      Chart kindly supplied by DOHA.

[16]      NACCHO, Submission. 13, p. 8.

[17]      DOHA, Submission 24, p. 6.

[18]      Correspondence to Committee from Queensland Health, 12 September 2011.

[19]      See for example, Memorandum of Understanding between the Commonwealth of Australia through the Department of Health and Aged Care and the State of Queensland through the Department of Health, Supply of PBS medicines to Queensland Health operated and/or funded remote area Aboriginal health services under the provisions of section 100 of the National Health Act 1953 (Cwlth), available at
http://www.health.qld.gov.au/atsihealth/documents/16911.pdf

[20]      DOHA, Submission 24, p. 6.

[21]      Detailed information about section 100 arrangements in Queensland government operated clinics is provided in correspondence to the committee from Queensland Health, 12 September 2011, available at http://aph.gov.au/Senate/committee/clac_ctte/pbs_medicines/submissions.htm

[22]      Pharmacy Guild of Australia, Submission 19, p. 11.

[23]      Ngaanyatjarra Health Service, Submission 18, pp 3; 5.

[24]      Pharmacy Information Kit –Section 100 Pharmacy Support Allowance Program, DOHA and Pharmacy Guild of Australia, 2008, pp 1-5, http://www.ruralpharmacy.com.au/LinkClick.aspx?fileticket=LKurJbHcR8U%3D&tabid=655&language=en-AU (accessed 18 July 2011).

[25]      Pharmacy Information Kit –Section 100 Pharmacy Support Allowance Program, Department of Health and Ageing and Pharmacy Guild of Australia, 2008, pp 1-6, http://www.ruralpharmacy.com.au/LinkClick.aspx?fileticket=LKurJbHcR8U%3D&tabid=655&language=en-AU (accessed 18 July 2011).

[26]      Website http://www.health.gov.au/internet/main/Publishing.nsf/Content/nmp-quality.htm (accessed 18 July 2011).

[27]      Website http://www.health.gov.au/internet/main/Publishing.nsf/Content/nmp-quality.htm (accessed 18 July 2011).

[28]      Centre for Remote Health, Submission 10, p. 5.

[29]      DOHA, Submission 24, p. 6.

[30]      NACCHO, Submission 13, pp 12-13.

[31]      NACCHO, Submission 13, pp 13-14.

[32]      The National Prescribing Service is a not for profit organisation established in 1998 to provide information to individuals and health professionals to allow them to make better decisions about medicines and medical tests, leading to better health and economic outcomes, NPS website, http://www.nps.org.au/about_us (accessed 4 October 2011).

[33]      National Prescribing Service, Submission 8, p. 3.

[34]      National Prescribing Service, Submission 8, p. 3.

[35]      NACCHO, Submission 13, p. 25.

Chapter 2 - Impact of the program

[1]        Kimberley Pharmacy Services, Submission 6, p. 2; Centre for Remote Health, Submission 10, p. 4; Australian Medical Association, Submission 12, p. 1; Mr Rollo Manning, Submission 26, p. 8; Name withheld, Submission 15, p. 1; Pharmacy Guild of Australia, Submission 19, p. 7.

[2]        Pharmacy Guild of Australia, Submission 19, p. 7.

[3]        Chart kindly supplied by DOHA.

[4]        DOHA, Submission 24, p. 9.

[5]        DOHA, Submission 24, p. 18.

[6]        Mr Roy Finnigan, Submission 3, p. 2.

[7]        Department of Health, Northern Territory, Submission 20, p. 1.

[8]        AMSANT, Submission 29, p. 7.

[9]        Pharmaceutical Society of Australia, Submission 7, p. 2; Centre for Remote Health, Submission 10, p. 5; Charles Sturt University, Submission 27, p. 3.

[10]      DOHA, Submission 24, p. 9.

[11]      Centre for Remote Health, Submission 10, p. 5.

[12]      Centre for Remote Health, Submission 10, p. 5.

[13]      Centre for Remote Health, Submission 10, p. 5.

[14]      Wurli-Wurlinjang Health Service, Submission 14, p. 5.

[15]      Centre for Chronic Disease, Submission 28, p. 2.

[16]      Correspondence from DOHA to the Committee, 12 September 2011.

[17]      Centre for Chronic Disease, Submission 28, p. 3.

[18]      Correspondence from DOHA to the Committee, 12 September 2011.

[19]      Drs Peter and Jan Bowman, Submission 1, p. 2.

[20]      Drs Peter and Jan Bowman, Submission 1, p. 2.

[21]      Pharmaceutical Society of Australia, Submission 7, p. 3. See also AIHW report The health and welfare of Aboriginal and Torres Strait Islander people: an overview 2011.

[22]      Ms Heidi Williams, Submission 5, p. 1.

[23]      Society of Hospital Pharmacists, Submission 2, p. 4.

[24]      Centre for Remote Health, Submission 10, p. 1.

[25]      Charles Sturt University, Submission 27, p. 2.

[26]      Charles Sturt University, Submission 27, p. 2.

[27]      DOHA, Submission 24, p. 10.

[28]      Table kindly supplied by DOHA.

[29]      Table kindly supplied by DOHA.

[30]      DOHA, Submission 24, p. 10.

[31]      DOHA, Submission 24, p. 10.

[32]      DOHA, Submission 24, p. 13.

[33]      National Rural Health Alliance, Submission 21, p. 4.

[34]      Kimberley Pharmacy Services, Submission 6, p. 2.

[35]      Pharmaceutical Society of Australia, Submission 7, p. 4. See also Pharmacy Guild of Australia, Submission 19, p. 21.

[36]      Pharmacy Guild of Australia, Submission 19, p. 21.

[37]      Kimberley Pharmacy Services, Submission 6, p. 3; Queensland Aboriginal and Islander Health Council, Submission 11, p. 6.

[38]      Pharmacy Guild of Australia, Submission 19, p. 19.

[39]      Mr Rollo Manning, Submission 26, p. 6.

[40]      Pharmaceutical Society of Australia, Submission 7, p. 5; NACCHO, Submission 13, p. 6.

[41]      Ngaanyatjarra Health Service, Submission 18, p. 8.

[42]      Correspondence from DOHA to the Committee, 12 September 2011.

[43]      DOHA, Submission 24, p. 9.

[44]      Drs Peter and Jan Bowman, Submission 1, pp 2-3.

[45]      Drs Peter and Jan Bowman, Submission 1, p. 4; Society of Hospital Pharmacists, Submission 2, p. 4.

[46]      Society of Hospital Pharmacists, Submission 2, p. 2.

[47]      Society of Hospital Pharmacists, Submission 2, p. 3.

[48]      Campbell Research and Consulting, Home Medicines Review Program - Qualitative Research Project, Final Report, December 2008, p. 5.

[49]      Ngaanyatjarra Health Service, Submission 18, p. 5.

[50]      Ngaanyatjarra Health Service, Submission 18, p. 5.

[51]      Also discussed by Drs Peter and Jan Bowman, Submission 1, pp 2-3.

[52]      Ngaanyatjarra Health Service, Submission 18, p. 5.

[53]      Ngaanyatjarra Health Service, Submission 18, p. 6.

[54]      Ngaanyatjarra Health Service, Submission 18, p. 6.

[55]      Pharmaceutical Society of Australia, Submission 7, pp. 7-8.

[56]      Centre for Remote Health, Submission 10, p. 7.

[57]      NACCHO, Submission 13, p. 24.

[58]      Kimberley Aboriginal Medical Services Council, Submission 22, pp 5-6

[59]      Correspondence to Committee from Queensland Health, 12 September 2011.

[60]      Mr Rollo Manning, Submission 26, p. 6.

[61]      AMSANT, Submission 29, p. 11.

[62]      Wurli-Wurlinjang Health Service, Submission 14.

[63]      Mr Rollo Manning, Submission 26, p. 3.

[64]      NACCHO, Submission 13, p. 27.

[65]      NACCHO, Submission 13, p. 6

[66]      Northern Territory Department of Health, Submission 20, p. 4.

[67]      Society of Hospital Pharmacists, Submission 2, p. 7.

[68]      Nova Public Policy, Evaluation of Indigenous Pharmacy Programs, p. 2.

[69]      Society of Hospital Pharmacists, Submission 2, p. 9.

[70]      Society of Hospital Pharmacists, Submission 2, p. 11.

[71]      Pharmaceutical Society of Australia, Submission 7, p. 6.

[72]      NACCHO, Submission 13, p. 22.

Chapter 3 - Compliance and Funding Distribution Issues

[1]        Centre for Remote Health, Submission 10, p. 7.

[2]        Australian Medical Association, Submission 12, p. 2.

[3]        Ngaanyatjarra Health Service, Submission 18, p. 12.

[4]        Kimberley Aboriginal Medical Services Council, Submission 22, p. 10.

[5]        Pharmacy Guild of Australia, Submission 19, p. 22.

[6]        Pharmacy Guild of Australia, Submission 19, p. 22.

[7]        Pharmacy Guild of Australia, Submission 19, p. 23.

[8]        DOHA, Submission 24, p. 11.

[9]        DOHA, Submission 24, p. 11.

[10]      Society of Hospital Pharmacists, Submission 2, p. 12.

[11]      Centre for Remote Health, Submission 10, p. 1.

[12]      See also Western Australian Branch of the Pharmacy Guild of Australia's submission, appendix to Pharmacy Guild of Australia, Submission 19, p. 52.

[13]      Pharmacy Guild of Australia, Submission 19, p. 24.

[14]      Pharmaceutical Society of Australia, Submission 7, p. 2.

[15]      Mr Rollo Manning, Submission 26, p. 8.

[16]      Kimberley Aboriginal Medical Services Council, Submission 22, p. 11.

[17]      Centre for Remote Health, Submission 10, p. 8.

[18]      Centre for Remote Health, Submission 10, p. 9.

[19]      Centre for Remote Health, Submission 10, p. 9.

[20]      Centre for Remote Health, Submission 10, p. 10.

[21]      Poisons and Dangerous Drugs Act (NT) 2011; Health (Drugs and & Poisons) Regulation 1996 (Qld).

[22]      Centre for Remote Health, Submission 10, pp 11-12.

[23]      Correspondence from DOHA to the Committee, 12 September 2011.

[24]      Correspondence from DOHA to the Committee, 12 September 2011.

[25]      Society of Hospital Pharmacists, Submission 2, p. 7.

[26]      Pharmacy Guild of Australia, Submission 19, p. 26.

[27]      Northern Territory Department of Health, Submission 20, p. 6.

Chapter 4 - Previous Reviews

[1]        Pharmacy Guild of Australia, Submission 19, p. 12.

[2]        Pharmacy Guild of Australia, Submission 19, p. 12.

[3]        Pharmacy Guild of Australia, Submission 19, p. 12.

[4]        Pharmacy Guild of Australia, Submission 19, p. 13.

[5]        Pharmacy Guild of Australia, Submission 19, p. 13.

[6]        Pharmacy Guild of Australia, Submission 19, p. 13.

[7]        Pharmacy Guild of Australia, Submission 19, p. 13

[8]        DOHA, Submission 24, pp 14-15.

[9]        NACCHO, Submission 13, p.17.

[10]      Mr Rollo Manning, Submission 26, p. 9.

[11]      DOHA, Submission 24, p. 17.

[12]      Pharmaceutical Society of Australia, Submission 7, p. 5.

[13]      NACCHO, Submission 13, pp 21, 22.

[14]      Swain L., Remote Rural Pharmacists Project, Australian Pharmacy Council, June 2009.

[15]      NACCHO, Submission 13, p. 24.

[16]      Ngaanyatjarra Health Service, Submission 18, p. 12.

[17]      Nova Public Policy, Evaluation of Indigenous Pharmacy Programs Report, 2010, p. 2.

[18]      Nova Public Policy, Evaluation of Indigenous Pharmacy Programs Report, 2010, p. 2.

[19]      Nova Public Policy, Evaluation of Indigenous Pharmacy Programs Report, 2010, p. 3.

[20]      DOHA, Submission 24, p. 17.

[21]      Society of Hospital Pharmacists, Submission 2, p. 13.

[22]      Kimberley Pharmacy Services, Submission 6, p. 4.

[23]      Pharmaceutical Society of Australia, Submission 7, p. 7.

[24]      Ngaanyatjarra Health Service, Submission 18, p. 14.

Chapter 5 - Other issues

[1]        NACCHO, Submission 13, p. 5

[2]        Society of Hospital Pharmacists, Submission 2, p. 12.

[3]        Centre for Remote Health, Submission 10, p. 14.

[4]        Australian Medical Association, Submission 12, p. 4.

[5]        South Australian Department of Health, Submission 17, pp 2-3.

[6]        Ngaanyatjarra Health Service, Submission 18, p. 7.

[7]        South Australian Department of Health, Submission 17, p. 3.

[8]        National Rural Health Alliance, Submission 21, p. 4; Minister for Health, NSW, Submission 25, p. 3.

[9]        Pharmacy Guild of Australia, Submission 19, p. 9

[10]      NACCHO, Submission 13, p 4; Queensland Aboriginal and Islander Health Council, Submission 11, p. 5.

[11]      NACCHO, Submission 13, p. 16.

[12]      Queensland Aboriginal and Islander Health Council, Submission 11, p. 6; NACCHO Submission 13, p. 5.

[13]      Centre for Remote Health, Submission 10, p. 14.

[14]      Campbell Research and Consulting, Home Medicines Review Program - Qualitative Research Project, Final Report, December 2008, p. 17.

[15]      Campbell Research and Consulting, Home Medicines Review Program - Qualitative Research Project, Final Report, December 2008, p. 5.

[16]      Ngaanyatjarra Health Service, Submission 18, p. 6.

[17]      Ngaanyatjarra Health Service, Submission 18, p. 7.

[18]      Royal Flying Doctor Service, Submission 9, p. 3.

[19]      Correspondence from DOHA to the Committee, 12 September 2011.